Default object view. Click to create a custom template, Node ID: 118594, Object ID: 70610

RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell...

RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial

No relation

Yes

No relation

No

07/09/2015 3:33 pm

No